BA
CLDX icon

Bridgewater Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bridgewater Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-567
Closed -$206K – 94
2013
Q4 		$206K Buy
+567
New +$206K 0.21% 75